明德生物(002932.SZ):擬投建科技產業園(一期)
格隆匯 8 月 3日丨明德生物(002932.SZ)公佈,2020年8月3日,公司召開第三屆董事會第九次會議,審議通過了《關於擬投資建設科技產業園的公告》,同意公司在上述募投項目建設的基礎上,以自籌資金的方式投資建設明德生物科技產業園(一期),其中自籌資金不超過人民幣2.7億元。此次投資將按照實際建設進度分期投入,該投資計劃目前尚未開展。
項目名稱為明德生物科技產業園(一期);擬投資建設的明德生物科技產業園(一期)項目,將在原計劃建設的募投項目——體外診斷試劑擴建項目、移動醫療產品建設項目及研發中心建設項目基礎上,自籌資金新建傳染性疾病體外診斷產品研發及產業化項目,力爭將明德生物科技產業園建成為國內專業化、規模化的一流體外診斷產品產業園區。
項目資金規模及資金來源:自籌資金不超過人民幣2.7億元,若加上原募投項目,則明德生物科技產業園(一期)項目整體投資規模不超過人民幣6億元。
科技產業園項目是圍繞公司主營業務展開,符合公司的發展戰略、國家相關的產業政策和市場技術的發展趨勢,科技產業園項目的建成能優化公司產能佈局,有效提升公司產品和服務質量,擴大品牌影響力,增強公司的綜合競爭力,對公司具有積極的戰略意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.